Pain med prescribing guidelines mostly agree

NEW YORK Wed Nov 13, 2013 10:12am EST

Related Topics

NEW YORK (Reuters Health) - Doctors are well aware that prescribing powerful painkillers known as opioids carries risks for addiction, misuse and accidental overdose - but at least professional guidelines agree on the precautions they can take, say researchers.

Opium-related drugs, like Oxycontin, Percocet, Percodan and methadone can be very addictive and are usually prescribed for just a week or two for intense short-term pain, though their use for longer-lasting pain is growing.

Sales of opiates in the U.S. increased by 300 percent since 1999, according to the Centers for Disease Control and Prevention. Three out of four deaths due to prescription drug overdose involve opioids. And for every death there are ten admissions to treatment centers for addiction.

The rapid rise in opioid use over the last ten years left little time to research best practices for giving out long-term prescriptions to treat chronic pain, according to Dr. Teryl Nuckols at the David Geffen School of Medicine at the University of California, Los Angeles.

Many organizations offer guidelines for doctors, but it wasn't clear if they agreed or differed greatly, he told Reuters Health. So he and colleagues set out to review the guidelines published since 2006.

Surprisingly, the team found that most of them agreed on key points.

"There is widespread agreement about some basic ways of mitigating the risks associated with prescribing opioids for chronic pain," Nuckols said.

"Guidelines often differ substantially, even when there is pretty good literature addressing the clinical questions," he said. As an example, he pointed to the question of giving screening mammograms to women ages 40 to 50, where there is much evidence but little agreement.

In their review, Nuckols' group assessed recommendations for doctors that drew on evidence for prescribing the powerful drugs to patients with non-cancer pain that lasts more than three months.

According to one study, 18 percent of people with this type of chronic pain use opioids.

Most guidelines recommended that clinicians avoid doses greater than 90 to 200 milligrams of "morphine equivalents" daily and that they have additional knowledge to prescribe methadone. Doctors should also increase dosages slowly and monitor for side effects when first prescribing the drugs, and reduce doses by at least 25 percent to 50 percent when switching opioids.

Guidelines agreed, as well, that opioid risk assessment tools, written treatment agreements and urine drug testing can help to manage risks of overdose and misuse Nuckols' team writes in the Annals of Internal Medicine.

More research is needed to determine the quality of these guidelines, the researchers note. And whether they're being followed by doctors is still another question.

"Unfortunately, guidelines are not followed as often as they should be," Nuckols said.

Doctors also make decisions based on online literature, lectures, journal articles, advice from other physicians and personal experience, he said.

Many of the recommendations pointed out in the review are not routinely used in many, if not most, clinical practices where opioids for chronic pain are prescribed, said Dr. Mel Pohl, medical director of the Las Vegas Recovery Center. He was not involved in the review.

Understanding dosing limits, knowing who is at risk of misusing, abusing or becoming addicted to prescribed opioids and what constitutes addiction versus the normal tolerance and dependence are important but nuanced aspects of prescribing these drugs, Martin D. Cheatle said.

Cheatle is director of the Pain and Chemical Dependency Program at the Center for Studies of Addiction at Perelman School of Medicine at the University of Pennsylvania in Philadelphia and also not involved in the review.

"Most medical school curriculums are notably lacking courses on pain and addiction," he told Reuters Health. "Since most of pain care is delivered by primary care physicians, who typically have the least amount of training, time and resources to manage these complex cases it is imperative that we disseminate critical and well vetted guidelines for safe opioid prescribing."

Educating doctors, especially primary care doctors, is the most important step, Cheatle said.

SOURCE: Annals of Internal Medicine, online November 12, 2013.

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see
Comments (1)
Guidelines should call for aggressive efforts to get treatment for those who become addicted.

Addiction is a chronic, progressive brain disease. It’s treatable. Perhaps not as successfully as one might like, but on a par with other chronic diseases that require substantial behavioral change, like diabetes and hypertension.

Unfortunately, many people still don’t believe addiction is a disease. That’s why science-based education is so important.

For a not-for-profit website that discusses the science of substance use and abuse in accessible English (how alcohol and drugs work in the brain; how addiction develops; why addiction is a chronic, progressive brain disease; what parts of the brain malfunction as a result of substance abuse; how that malfunction skews decision-making and motivation, resulting in addict behaviors; why some get addicted while others don’t; how treatment works; how well treatment works; why relapse is common; what family and friends can do; etc.) please click on

Nov 15, 2013 1:20pm EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.